MCHX / Marchex, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Marchex, Inc.
US ˙ NasdaqGS ˙ US56624R1086

Mga Batayang Estadistika
LEI 391200Z7ZWISADXEGZ47
CIK 1224133
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Marchex, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
August 13, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 0

August 12, 2025 EX-99.1

Marchex Announces Second Quarter 2025 Results

Exhibit 99.1 Marchex Announces Second Quarter 2025 Results SEATTLE, WA – August 12, 2025 – Marchex, Inc. (NASDAQ: MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced its financial results for the second quarter ended June 30, 2025. Q2 2025 Financial Highlights • GAAP revenue was $11.7 million for the secon

August 12, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2025 Marchex, Inc. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2025 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

May 14, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number

May 13, 2025 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2025 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number)

May 13, 2025 EX-99.1

Marchex Announces First Quarter 2025 Results and New Share Repurchase Program Showcases Strategic Milestones in Two-Year Transformation to AI-Powered Prescriptive Analytics Leader

Exhibit 99.1 Marchex Announces First Quarter 2025 Results and New Share Repurchase Program Showcases Strategic Milestones in Two-Year Transformation to AI-Powered Prescriptive Analytics Leader SEATTLE, WA – May 13, 2025 – Marchex, Inc. (NASDAQ: MCHX), which harnesses the power of artificial intelligence ("AI") and conversational intelligence to drive revenue acceleration and operational excellence

April 18, 2025 EX-19.1

Policy For Securities Transactions

Exhibit 19.1 POLICY FOR SECURITIES TRANSACTIONS Securities Transactions Insider Trading Purpose For many years, the SEC and the U.S. Attorneys have been vigorously pursuing violations of insider trading laws. In 1998, to further deter insider trading violations, Congress expanded the authority of the SEC and the Justice Department by adopting the Insider Trading and Securities Fraud Enforcement Ac

April 18, 2025 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO For the tr

March 25, 2025 EX-FILING FEES

Filing Fee Table

Exhibit 107 CALCULATION OF FILING FEE TABLE FORM S-8 (FORM TYPE) MARCHEX, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) TABLE 1: NEWLY REGISTERED SECURITIES Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity 2021 Stock Incentive Plan, Class B

March 25, 2025 S-8

As filed with the Securities and Exchange Commission on March 25, 2025

As filed with the Securities and Exchange Commission on March 25, 2025 Registration No.

March 21, 2025 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2025 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numbe

March 14, 2025 EX-31.1(I)

Certification of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31.1(i) CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Edwin Miller, certify that: 1. I have reviewed this Annual Report on Form 10-K of Marchex, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statemen

March 14, 2025 EX-31.1(II)

Certification of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31.1(ii) CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Brian Nagle, certify that: 1. I have reviewed this Annual Report on Form 10-K of Marchex, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statemen

March 14, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-506

March 14, 2025 EX-97.1

Policy for Recovery of Executive Compensation

POLICY FOR RECOVERY OF INCENTIVE COMPENSATION If Marchex, Inc. (the “Company”) determines it must prepare a restatement, the Company will seek to recover the amount of erroneously awarded incentive compensation received by a covered officer, as provided below. For purposes of this policy, the term (i) “restatement” means an accounting restatement due to the material noncompliance of the Company wi

March 14, 2025 EX-21.1

Subsidiaries of the Registrant.

List of Subsidiaries of the Registrant Name Jurisdiction 1. Marchex Paymaster, LLC Delaware 2. Marchex, LLC Delaware 3. Marchex Sales, LLC Delaware 4. Marchex CAH, Inc. Delaware 5. Telmetrics Corporation (formerly, Telmetrics Inc.) Nova Scotia 6. Marchex International, Ltd.(1) Ireland 7. Archonic, LLC(2) Delaware 8. Callcap, LLC (formerly, SITA Laboratories, Inc.) Delaware 9. DCCI Support Service,

March 6, 2025 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2025 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number

March 6, 2025 EX-99.1

Marchex Announces Fourth Quarter and Full Year 2024 Results

Exhibit 99.1 Marchex Announces Fourth Quarter and Full Year 2024 Results SEATTLE, WA – March 6, 2025 – Marchex, Inc. (NASDAQ: MCHX), which harnesses the power of artificial intelligence ("AI") and conversational intelligence to drive operational excellence and revenue acceleration, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Q4 2024 and Full

January 10, 2025 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2025 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Num

December 31, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2024 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Nu

November 7, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2024 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Num

November 1, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Num

October 31, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2024 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Num

October 31, 2024 EX-99.1

Marchex Announces Third Quarter 2024 Results

Exhibit 99.1 Marchex Announces Third Quarter 2024 Results SEATTLE, WA – October 31, 2024 – Marchex, Inc. (NASDAQ: MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced its financial results for the third quarter ended September 30, 2024. Q3 2024 Financial Highlights • GAAP revenue was $12.6 million for the t

September 18, 2024 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin

September 18, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

August 13, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 0

August 8, 2024 EX-99.1

Marchex Announces Second Quarter 2024 Results

Exhibit 99.1 Marchex Announces Second Quarter 2024 Results SEATTLE, WA – August 8, 2024 – Marchex, Inc. (NASDAQ: MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced its financial results for the second quarter ended June 30, 2024. Q2 2024 Financial Highlights • GAAP revenue was $12.1 million for the second

August 8, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numbe

July 29, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2024 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number

May 14, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number

May 8, 2024 8-K/A

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2024 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Comm

May 8, 2024 EX-99.1

Marchex Announces First Quarter Results

Exhibit 99.1 Marchex Announces First Quarter Results SEATTLE – May 7, 2024 – Marchex, Inc. (NASDAQ: MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced its financial results for the first quarter ended March 31, 2024. Q1 2024 Financial Highlights • GAAP revenue was $11.6 million for the first quarter of 20

May 7, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2024 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number)

May 7, 2024 EX-99.1

Marchex Announces First Quarter Results

Exhibit 99.1 Marchex Announces First Quarter Results SEATTLE – May 7, 2024 – Marchex, Inc. (NASDAQ: MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced its financial results for the first quarter ended March 31, 2024. Q1 2024 Financial Highlights • GAAP revenue was $11.6 million for the first quarter of 20

April 29, 2024 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO For the transition period fr

April 22, 2024 S-8

As filed with the Securities and Exchange Commission on April 22, 2024

As filed with the Securities and Exchange Commission on April 22, 2024 Registration No.

April 22, 2024 EX-FILING FEES

Filing Fee Table

Exhibit 107 CALCULATION OF FILING FEE TABLE FORM S-8 (FORM TYPE) MARCHEX, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) TABLE 1: NEWLY REGISTERED SECURITIES Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity 2021 Stock Incentive Plan, Class B

April 1, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-50658 Marchex, Inc. (

April 1, 2024 EX-21.1

Subsidiaries of the Registrant.

List of Subsidiaries of the Registrant Name Jurisdiction 1. Marchex Paymaster, LLC Delaware 2. Marchex, LLC Delaware 3. Marchex Sales, LLC Delaware 4. Marchex CAH, Inc. Delaware 5. Telmetrics Corporation (formerly, Telmetrics Inc.) Nova Scotia 6. Marchex International, Ltd. Ireland 7. Archonic, LLC Delaware 8. Callcap, LLC (formerly, SITA Laboratories, Inc.) Delaware 9. DCCI Support Service, Inc.

April 1, 2024 EX-31.1(II)

Certification of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31.1(ii) CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Holly A. Aglio, certify that: 1. I have reviewed this Annual Report on Form 10-K of Marchex, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the state

April 1, 2024 EX-31.1(I)

Certification of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31.1(i) CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Edwin Miller, certify that: 1. I have reviewed this Annual Report on Form 10-K of Marchex, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statemen

April 1, 2024 EX-97.1

Policy for Recovery of Executive Compensation

POLICY FOR RECOVERY OF INCENTIVE COMPENSATION If Marchex, Inc. (the “Company”) determines it must prepare a restatement, the Company will seek to recover the amount of erroneously awarded incentive compensation received by a covered officer, as provided below. For purposes of this policy, the term (i) “restatement” means an accounting restatement due to the material noncompliance of the Company wi

March 14, 2024 EX-99.1

Marchex Announces Fourth Quarter and Full Year 2023 Results

Exhibit 99.1 Marchex Announces Fourth Quarter and Full Year 2023 Results SEATTLE – March 14, 2024 – Marchex, Inc. (NASDAQ: MCHX), which harnesses the power of AI and conversational intelligence to provide actionable insights aligned with prescriptive vertical market data analytics, driving operational excellence and revenue acceleration, today announced its financial results for the fourth quarter

March 14, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2024 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numbe

March 1, 2024 SC 13G/A

MCHX / Marchex, Inc. / B. Riley Financial, Inc. - AMENDMENT NO. 3 TO SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Marchex, Inc. (Name of Issuer) Class B Common Stock, $0.01 par value per share (Title of Class of Securities) 56624R108 (CUSIP Number) February 28, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the ru

February 14, 2024 SC 13G

MCHX / Marchex, Inc. / HOROWITZ RUSSELL C - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 16)* Marchex, Inc. (Name of Issuer) Class B Common Stock (Title of Class of Securities) 56624R 10 8 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi

February 13, 2024 SC 13G/A

MCHX / Marchex, Inc. / B. Riley Financial, Inc. - AMENDMENT NO. 2 TO SCHEDULE 13G Passive Investment

SC 13G/A 1 ea193635-13ga2brileymarchex.htm AMENDMENT NO. 2 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Marchex, Inc. (Name of Issuer) Class B Common Stock, $0.01 par value per share (Title of Class of Securities) 56624R108 (CUSIP Number) December 31, 2023 (Date of Event which Requi

February 9, 2024 SC 13G/A

MCHX / Marchex, Inc. / Koller Capital LLC - SC 13G/A Passive Investment

SC 13G/A 1 tm245713d1sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Marchex, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 56624R108 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate

February 8, 2024 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 2)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 2) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Numbe

February 8, 2024 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 2)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 2) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number

January 16, 2024 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Numbe

January 16, 2024 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number

November 15, 2023 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2023 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Nu

November 13, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marc

November 13, 2023 SC 13D/A

MCHX / Marchex Inc - Class B / Edenbrook Capital, LLC - FORM SC 13D/A Activist Investment

SC 13D/A 1 formsc13da.htm FORM SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 18) Marchex, Inc. (Name of Issuer) Class B common stock, par value $0.01 per share (Title of Class of Securities) 56624R108 (CUSIP Number) Jonathan Brolin Edenbrook Capital, LLC 116 Radio Circle Mount Kisco, NY 10549

November 8, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2023 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Num

November 8, 2023 EX-99.1

Marchex Announces Third Quarter 2023 Results

Exhibit 99.1 Marchex Announces Third Quarter 2023 Results SEATTLE – November 8, 2023 – Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced its financial results for the third quarter ended September 30, 2023. Q3 2023 Financial Highligh

October 31, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2023 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Num

October 31, 2023 EX-99.1

Marchex Hires Holly Aglio as Chief Financial Officer

Exhibit 99.1 Marchex Hires Holly Aglio as Chief Financial Officer SEATTLE – October 31, 2023- Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced that Holly Aglio has joined the company as Chief Financial Officer. Aglio is a seasoned f

October 2, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2023 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction (Commission File Number) (I.R.S. Emp

September 5, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2023 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

August 18, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

August 18, 2023 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin

August 4, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex,

August 3, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2023 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numbe

August 3, 2023 EX-99.1

Marchex Announces Second Quarter 2023 Results

Exhibit 99.1 Marchex Announces Second Quarter 2023 Results SEATTLE – August 3, 2023 – Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced its financial results for the second quarter ended June 30, 2023. Q2 2023 Financial Highlights •

May 5, 2023 EX-10.26

Independent Contractor Agreement dated February 3, 2023 by and between Russell C. Horowitz and the Registrant (incorporated by reference to Exhibit 10.26 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on May 5, 2023)

February 3, 2023 SENT VIA EMAIL Dear Russ: This letter sets forth the agreement and terms pursuant to which you personally will provide certain services as an independent contractor consultant for the benefit of Marchex, Inc.

May 5, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex,

May 4, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number)

May 4, 2023 EX-99.1

Marchex Announces First Quarter 2023 Results

Exhibit 99.1 Marchex Announces First Quarter 2023 Results SEATTLE –May 4, 2023- Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced its financial results for the first quarter ended March 31, 2023. Q1 2023 Financial Highlights • GAAP r

May 1, 2023 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marc

April 18, 2023 EX-FILING FEES

Filing Fee Table

Exhibit 107 CALCULATION OF FILING FEE TABLE FORM S-8 (FORM TYPE) MARCHEX, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) TABLE 1: NEWLY REGISTERED SECURITIES Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity 2021 Stock Incentive Plan, Class B

April 18, 2023 S-8

As filed with the Securities and Exchange Commission on April 18, 2023

As filed with the Securities and Exchange Commission on April 18, 2023 Registration No.

April 4, 2023 EX-99.1

Marchex Hires Troy Hartless as Chief Revenue Officer

Exhibit 99.1 Marchex Hires Troy Hartless as Chief Revenue Officer SEATTLE - April 4, 2023- Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced that Troy Hartless has joined the company as Chief Revenue Officer. Hartless has extensive e

April 4, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2023 Marchex, Inc. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2023 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number

March 31, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-50658 Marchex, Inc. (

March 31, 2023 EX-21.1

Subsidiaries of the Registrant.

Exhibit 21.1 List of Subsidiaries of the Registrant Name Jurisdiction 1. Marchex Paymaster, LLC Delaware 2. Marchex, LLC Delaware 3. Marchex Sales, LLC Delaware 4. Marchex CAH, Inc. Delaware 5. Telmetrics Corporation (formerly, Telmetrics Inc.) Nova Scotia 6. Marchex International, Ltd. Ireland 7. Archonic, LLC Delaware 8. Callcap, LLC (formerly, SITA Laboratories, Inc.) Delaware 9. DCCI Support S

March 31, 2023 EX-10.25

Sublease effective as of January 5, 2023, between the Board of Regents of the University of Washington and the Registrant (incorporated by reference to Exhibit 10.25 to the Registrant’s Annual Report on Form 10-K filed with the SEC on March 31, 2023)

DocuSign Envelope ID: EA9B96EB-3D5B-4638-83EA-9F41841AF777Exhibit 10.25 Jones Lang LaSalle 601 Union St. Ste 2800 Seattle, WA 98101 Phone: 206-607-1700 Fax: 206-607-1701 DocuSign Envelope ID: EA9B96EB-3D5B-4638-83EA-9F41841AF777Exhibit 10.25 © Commercial Brokers Association ALL RIGHTS RESERVED Form• SUB LS Sublease Agreement Rev. 9/2020 SUBLEASE AGREEMENT THIS SUBLEASE AGREEMENT ("Sublease") is en

March 31, 2023 EX-31.I

Certification of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31.1(ii) CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Michael A. Arends, certify that: 1. I have reviewed this Annual Report on Form 10-K of Marchex, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the st

March 31, 2023 EX-31.II

Certification of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31.1(i) CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Edwin Miller, certify that: 1. I have reviewed this Annual Report on Form 10-K of Marchex, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statemen

March 14, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2023 Marchex, Inc. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2023 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numbe

March 13, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2023 Marchex, Inc. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2023 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numbe

February 28, 2023 EX-99.1

Marchex Announces Fourth Quarter and Full Year 2022 Results

Exhibit 99.1 Marchex Announces Fourth Quarter and Full Year 2022 Results SEATTLE –February 28, 2023- Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced its financial results for the fourth quarter and year ended December 31, 2022. Q4

February 28, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 Marchex, Inc. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Nu

February 13, 2023 SC 13G/A

MCHX / Marchex, Inc. / HOROWITZ RUSSELL C - SC 13G/A Passive Investment

SC 13G/A 1 none-sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 15)* Marchex, Inc. (Name of Issuer) Class B Common Stock (Title of Class of Securities) 56624R 10 8 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desi

February 8, 2023 SC 13G

MCHX / Marchex, Inc. / Koller Capital LLC - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Marchex, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 56624R108 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i

February 6, 2023 EX-99.1

Marchex Appoints Edwin Miller as New CEO Ryan Polley, Chief Operating Officer, Also Promoted to the Role of President

Exhibit 99.1 Marchex Appoints Edwin Miller as New CEO Ryan Polley, Chief Operating Officer, Also Promoted to the Role of President SEATTLE-(BUSINESS WIRE)—February 6, 2023- Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced that Edwin

February 6, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2023 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Num

February 3, 2023 SC 13G/A

MCHX / Marchex, Inc. / B. Riley Financial, Inc. - AMENDMENT NO. 1 TO SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Marchex, Inc. (Name of Issuer) Class B Common Stock, $0.01 par value per share (Title of Class of Securities) 56624R108 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the ru

January 26, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2023 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Num

December 30, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2022 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Nu

December 22, 2022 8-K

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

mchx-8k20221220.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2022 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation)

November 15, 2022 8-K

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2022 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Nu

November 15, 2022 EX-16.1

Letter dated November 15, 2022 from Moss Adams to the SEC

Exhibit 16.1 November 15, 2022 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read the statements made by Marchex, Inc. included under Item 4.01 of its Current Report on Form 8-K dated November 11, 2022, to be filed with the Securities and Exchange Commission. We agree with the statements concerning our Firm contained therein. Sincerely, /s

November 4, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marc

November 3, 2022 EX-99.1

Marchex Announces Third Quarter 2022 Results

Exhibit 99.1 Marchex Announces Third Quarter 2022 Results SEATTLE ?November 3, 2022- Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced its financial results for the third quarter ended September 30, 2022. Q3 2022 Financial Highlights

November 3, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2022 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Num

October 3, 2022 8-K

Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2022 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File N

September 16, 2022 8-K

Termination of a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 12, 2022 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File N

August 19, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

August 19, 2022 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

August 10, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex,

August 9, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2022 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numbe

August 9, 2022 EX-99.1

Marchex Announces Second Quarter 2022 Results

Exhibit 99.1 Marchex Announces Second Quarter 2022 Results SEATTLE ?August 9, 2022- Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced its financial results for the second quarter ended June 30, 2022. Q2 2022 Financial Highlights ? GA

May 13, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex,

May 12, 2022 EX-99.1

Marchex Announces First Quarter 2022 Results

Exhibit 99.1 Marchex Announces First Quarter 2022 Results SEATTLE ?May 12, 2022- Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced its financial results for the first quarter ended March 31, 2022. Q1 2022 Financial Highlights ? GAAP

May 12, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2022 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number)

April 29, 2022 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marc

April 15, 2022 S-8

As filed with the Securities and Exchange Commission on April 15, 2022

As filed with the Securities and Exchange Commission on April 15, 2022 Registration No.

April 15, 2022 EX-FILING FEES

Filing Fee Table

Exhibit 107 CALCULATION OF FILING FEE TABLE FORM S-8 (FORM TYPE) MARCHEX, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) TABLE 1: NEWLY REGISTERED SECURITIES Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity 2021 Stock Incentive Plan, Class B

March 29, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

, -PSince this UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-50658

March 29, 2022 EX-10.22

Form of Nonstatutory Stock Option Notice and Agreement (2021 Stock Incentive Plan).

Exhibit 10.22 Marchex, Inc. 2021 Stock Incentive Plan Nonstatutory Stock Option Notice This Notice evidences the award of nonstatutory stock options (each, an ?Option? or collectively, the ?Options?) that have been granted to you, , subject to and conditioned upon your agreement to the terms of the attached Nonstatutory Stock Option Agreement (the ?Agreement?). The Options entitle you to purchase

March 29, 2022 EX-10.23

Form of Restricted Stock Agreement (2021 Stock Incentive Plan).

Exhibit 10.23 Marchex, Inc. 2021 Stock Incentive Plan Restricted Stock Agreement This Agreement (the ?Agreement?) evidences the award of restricted shares (each, an ?Award Share,? and collectively, the ?Award Shares?) of the Class B Common Stock of Marchex, Inc., a Delaware corporation (the ?Company?), granted to you, , effective as of (the ?Grant Date?), pursuant to the Marchex, Inc. 2021 Stock I

March 29, 2022 EX-21.1

Subsidiaries of the Registrant.

Exhibit 21.1 List of Subsidiaries of the Registrant Name Jurisdiction 1. Marchex Paymaster, LLC Delaware 2. Marchex, LLC Delaware 3. Marchex Sales, LLC Delaware 4. Marchex CAH, Inc. Delaware 5. Telmetrics Corporation (formerly, Telmetrics Inc.) Nova Scotia 6. Marchex International, Ltd. Ireland 7. Marchex Voice Services, Inc. Pennsylvania 8. Archonic, LLC Delaware 9. Callcap, LLC (formerly, SITA L

March 29, 2022 EX-10.21

Form of Incentive Stock Option Notice and Agreement (2021 Stock Incentive Plan).

Exhibit 10.21 Marchex, Inc. 2021 Stock Incentive Plan Incentive Stock Option Notice This Notice evidences the award of incentive stock options (each, an ?Option? or collectively, the ?Options?) that have been granted to you, , subject to and conditioned upon your agreement to the terms of the attached Incentive Stock Option Agreement (the ?Agreement?). The Options entitle you to purchase shares of

March 29, 2022 EX-10.24

Form of Restricted Stock Units Notice and Agreement (2021 Stock Incentive Plan).

Exhibit 10.24 Marchex, Inc. 2021 Stock Incentive Plan Restricted Stock Units Notice Name of Grantee: This Notice evidences the award of restricted stock units (each, an ?RSU,? and collectively, the ?RSUs?) of Marchex, Inc., a Delaware corporation (the ?Company?), that have been granted to you pursuant to the Marchex, Inc. 2021 Stock Incentive Plan (the ?Plan?) and conditioned upon your agreement t

March 29, 2022 EX-31.I

Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31(i) CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Michael A.

March 10, 2022 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2022 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number

March 2, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2022 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number

March 2, 2022 EX-99.1

Marchex Announces Fourth Quarter and Full Year 2021 Results

Exhibit 99.1 Marchex Announces Fourth Quarter and Full Year 2021 Results SEATTLE ?March 2, 2022- Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced its financial results for the fourth quarter and year ended December 31, 2021. Q4 2021

February 11, 2022 SC 13G

MCHX / Marchex, Inc. / B. Riley Financial, Inc. - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Marchex, Inc. (Name of Issuer) Class B Common Stock, $0.01 par value per share (Title of Class of Securities) 56624R108 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic

February 11, 2022 SC 13G/A

MCHX / Marchex, Inc. / HOROWITZ RUSSELL C - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13)* Marchex, Inc. (Name of Issuer) Class B Common Stock (Title of Class of Securities) 56624R 10 8 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi

January 4, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2022 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

January 3, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2021 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Nu

December 30, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2021 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Nu

December 22, 2021 S-8

As filed with the Securities and Exchange Commission on December 22, 2021

As filed with the Securities and Exchange Commission on December 22, 2021 Registration No.

November 23, 2021 SC 13D/A

MCHX / Marchex, Inc. / Edenbrook Capital, LLC - FORM SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 17) Marchex, Inc. (Name of Issuer) Class B common stock, par value $0.01 per share (Title of Class of Securities) 56624R108 (CUSIP Number) Jonathan Brolin Edenbrook Capital, LLC 116 Radio Circle Mount Kisco, NY 10549 (914) 239-3117 (Name, Address and Telep

November 10, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

erf UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658

November 9, 2021 EX-99.1

Marchex Announces Third Quarter 2021 Results

Exhibit 99.1 Marchex Announces Third Quarter 2021 Results SEATTLE ? November 9, 2021- Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced its financial results for the third quarter ended September 30, 2021. Q3 2021 Financial Highlight

November 9, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2021 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Num

October 4, 2021 8-K

Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2021 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

August 20, 2021 DEF 14A

Marchex, Inc. 2021 Stock Incentive Plan (Filed with Appendix A of the Registrant’s Definitive Proxy Statement on Schedule 14A filed with the SEC on August 20, 2021 and incorporated herein by reference).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

August 20, 2021 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

August 17, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2021 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

August 12, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

erf UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 March

August 5, 2021 EX-99.1

Marchex Announces Second Quarter 2021 Results

Exhibit 99.1 Marchex Announces Second Quarter 2021 Results SEATTLE ? August 5, 2021- Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced its financial results for the second quarter ended June 30, 2021. Q2 2021 Financial Highlights ? G

August 5, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2021 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numbe

May 13, 2021 EX-99.1

Marchex Announces First Quarter 2021 Results

Exhibit 99.1 Marchex Announces First Quarter 2021 Results SEATTLE ? May 13, 2021- Marchex, Inc. (NASDAQ: MCHX), a leading conversational analytics and solutions company that connects the voice of the customer to your business, today announced its financial results for the first quarter ended March 31, 2021. Q1 2021 Financial Highlights1 ? GAAP revenue was $13.0 million for the first quarter of 202

May 13, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2021 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number)

May 13, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

erf UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marc

April 30, 2021 EX-31.II

Certification of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31(ii) CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Leila Kirske, certify that: 1.

April 30, 2021 EX-31.I

Certification of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31(i) CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Michael A.

April 30, 2021 10-K/A

Annual Report - 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marc

April 15, 2021 S-8

- S-8

As filed with the Securities and Exchange Commission on April 15, 2021 Registration No.

April 6, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2021 Marchex, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 000-50658 35-2194038 (State or Other Jurisdiction of Incorporation) (Commission File Number

April 6, 2021 EX-99.1

Marchex Announces New Chief Financial Officer and Executive Officer Evolution

Exhibit 99.1 Marchex Announces New Chief Financial Officer and Executive Officer Evolution SEATTLE—(BUSINESSWIRE)— April 6, 2021 - Marchex (NASDAQ: MCHX), a leading conversational analytics and solutions company that connects the voice of the customer to your business, today announced that it has promoted Leila Kirske to Chief Financial Officer, effective immediately. In this role, Kirske will lea

March 31, 2021 EX-31.I

Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31(i) CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Michael A.

March 31, 2021 EX-21.1

Subsidiaries of the Registrant.

Exhibit 21.1 List of Subsidiaries of the Registrant Name Jurisdiction 1. Marchex Paymaster, LLC Delaware 2. goClick.com, Inc. Delaware 3. Marchex, LLC Delaware 4. Marchex Sales, LLC Delaware 5. Marchex CAH, Inc. Delaware 6. Telmetrics Corporation (formerly, Telmetrics Inc.) Nova Scotia 7. Marchex International, Ltd. Ireland 8. Marchex Voice Services, Inc. Pennsylvania 9. Marchex Europe Limited Uni

March 31, 2021 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

PSince this UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-50658 Mar

March 8, 2021 SC 13D/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.

March 2, 2021 EX-99.1

Marchex Announces Fourth Quarter and Full Year 2020 Results

Exhibit 99.1 Marchex Announces Fourth Quarter and Full Year 2020 Results SEATTLE – March 2, 2021- Marchex, Inc. (NASDAQ: MCHX), a leading conversational analytics and solutions company that connects the voice of the customer to your business, today announced its financial results for the fourth quarter and full year ended December 31, 2020. Q4 and Full Year 2020 Financial Highlights1 • GAAP revenu

March 2, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2021 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number

January 29, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13)* Marchex, Inc. (Name of Issuer) Class B Common Stock (Title of Class of Securities)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13)* Marchex, Inc. (Name of Issuer) Class B Common Stock (Title of Class of Securities) 56624R 10 8 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi

January 4, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement - 8-K - JAN 4 2021 EXECUTIVE COMPENSATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Nu

December 8, 2020 POS AM

- POS AM

As filed with the Securities and Exchange Commission on December 8, 2020 Registration No.

November 18, 2020 S-3/A

As filed with the Securities and Exchange Commission on November 18, 2020

Table of Contents As filed with the Securities and Exchange Commission on November 18, 2020 Registration No.

November 18, 2020 CORRESP

-

Acceleration Letter MARCHEX, INC. 520 Pike Street, Suite 2000 Seattle, WA 98101 November 18, 2020 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Daniel Morris Re: Marchex, Inc. Amendment No. 1 to Registration Statement on Form S-3 File No. 333-249952 (the “Registration Statement”) Dear Mr. Lamparski: In accordance with Rule 461 of the General

November 6, 2020 S-3

Power of Attorney.

As filed with the Securities and Exchange Commission on November 6, 2020 Registration No.

November 5, 2020 10-Q

Quarterly Report - 10-Q3 2020

erf UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658

November 4, 2020 EX-99.1

Marchex Announces Third Quarter 2020 Results

Exhibit 99.1 Marchex Announces Third Quarter 2020 Results SEATTLE – November 4, 2020- Marchex, Inc. (NASDAQ:MCHX), a leading conversational analytics company that connects the voice of the customer to your business, today announced its financial results for the third quarter ended September 30, 2020. Q3 2020 Financial Highlights • Revenue was $26.5 million for the third quarter of 2020, compared t

November 4, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Num

October 23, 2020 8-K

- 8-K DIRECTOR COMP 2020

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Num

October 19, 2020 8-K

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets - 8-K TRANSACTION CLOSING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Num

October 19, 2020 EX-99.1

UNAUDITED PRO FORMA CONDENSED FINANCIAL INFORMATION

Exhibit 99.1 UNAUDITED PRO FORMA CONDENSED FINANCIAL INFORMATION The following unaudited pro forma condensed consolidated financial statements are derived from the historical consolidated financial statements of Marchex, Inc. (“Marchex” or the “Company”) as of and for the six months ended June 30, 2020, and for the years ended December 31, 2018 and 2019, which are incorporated by reference herein.

October 19, 2020 SC 13D/A

MCHX / Marchex, Inc. / Harbert Discovery Fund, LP Activist Investment

Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.

October 8, 2020 SC TO-T/A

MCHX / Marchex, Inc. / Edenbrook Capital, LLC - SC TO-T/A

SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 AMENDMENT NO. 2 MARCHEX, INC. (Name of Subject Company (Issuer)) Marchex, Inc. Edenbrook Capital, LLC Edenbrook Long Only Value Fund, LP Edenbrook Value Fund, LP Jonathan Brolin (Name of Filing Persons (Offero

October 8, 2020 SC TO-I/A

- SC TO-I/A

SC TO-I/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 AMENDMENT NO. 2 MARCHEX, INC. (Name of Subject Company (Issuer)) Marchex, Inc. Edenbrook Capital, LLC Edenbrook Long Only Value Fund, LP Edenbrook Value Fund, LP Jonathan Brolin (Name of Filing Persons (Offero

October 8, 2020 EX-99.(A)(1)(H)

MARCHEX AND EDENBROOK CAPITAL ANNOUNCE RESULTS OF TENDER OFFER FOR UP TO 10 MILLION SHARES OF CLASS B COMMON STOCK OF MARCHEX

EX-99.(a)(1)(H) Exhibit (a)(1)(H) MARCHEX AND EDENBROOK CAPITAL ANNOUNCE RESULTS OF TENDER OFFER FOR UP TO 10 MILLION SHARES OF CLASS B COMMON STOCK OF MARCHEX SEATTLE—(BUSINESSWIRE)— October 8, 2020 – Marchex (NASDAQ: MCHX), a leading conversational analytics company that connects the voice of the customer to your business, announced today the results of joint and equal tender offer with Edenbroo

October 8, 2020 EX-99.1

MARCHEX AND EDENBROOK CAPITAL ANNOUNCE RESULTS OF TENDER OFFER FOR UP TO 10 MILLION SHARES OF CLASS B COMMON STOCK OF MARCHEX

Exhibit 99.1 MARCHEX AND EDENBROOK CAPITAL ANNOUNCE RESULTS OF TENDER OFFER FOR UP TO 10 MILLION SHARES OF CLASS B COMMON STOCK OF MARCHEX SEATTLE—(BUSINESSWIRE)— October 8, 2020 – Marchex (NASDAQ: MCHX), a leading conversational analytics company that connects the voice of the customer to your business, announced today the results of joint and equal tender offer with Edenbrook Capital, LLC of up

October 8, 2020 8-K

Financial Statements and Exhibits, Other Events - 8-K TENDER OFFER RESULTS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

October 8, 2020 EX-99.(A)(1)(H)

MARCHEX AND EDENBROOK CAPITAL ANNOUNCE RESULTS OF TENDER OFFER FOR UP TO 10 MILLION SHARES OF CLASS B COMMON STOCK OF MARCHEX

EX-99.(a)(1)(H) Exhibit (a)(1)(H) MARCHEX AND EDENBROOK CAPITAL ANNOUNCE RESULTS OF TENDER OFFER FOR UP TO 10 MILLION SHARES OF CLASS B COMMON STOCK OF MARCHEX SEATTLE—(BUSINESSWIRE)— October 8, 2020 – Marchex (NASDAQ: MCHX), a leading conversational analytics company that connects the voice of the customer to your business, announced today the results of joint and equal tender offer with Edenbroo

October 2, 2020 8-K

Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders - 8-K 2020 ANNUAL MEETING ITEMS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

September 23, 2020 EX-99.A1D

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(a)(1)(D) Exhibit (a)(1)(D) Offer to Purchase for Cash by MARCHEX, INC. and EDENBROOK CAPITAL, LLC of Up to 10,000,000 Shares of Class B Common Stock of Marchex, Inc. at a Purchase Price of $2.15 Per Share THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., NEW YORK CITY TIME, ON OCTOBER 7, 2020 UNLESS THE OFFER IS EXTENDED (SUCH DATE AND TIME, AS THEY MAY BE EXTENDE

September 23, 2020 EX-99.A1A

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(a)(1)(A) Exhibit (a)(1)(A) Amended and Restated Offer to Purchase for Cash by Marchex, Inc. and Edenbrook Capital, LLC of Up to 10,000,000 shares of Class B common stock of Marchex, Inc. at a Purchase Price of $2.15 per share THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., NEW YORK CITY TIME, ON OCTOBER 7, 2020 UNLESS THE OFFER IS EXTENDED (SUCH DATE AND TIME, A

September 23, 2020 EX-99.A1G

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(a)(1)(G) Exhibit (a)(1)(G) Marchex Announces Increase in Purchase Price to $2.15 per share in the Joint Tender Offer with Edenbrook Capital for Up to 10 million Shares of Marchex’s Class B Common Stock SEATTLE—(BUSINESSWIRE)— September 23, 2020 – Marchex (NASDAQ: MCHX), a leading conversational analytics company that connects the voice of the customer to your business, announced today an in

September 23, 2020 EX-99.(A)(1)(D)

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(a)(1)(D) Exhibit (a)(1)(D) Offer to Purchase for Cash by MARCHEX, INC. and EDENBROOK CAPITAL, LLC of Up to 10,000,000 Shares of Class B Common Stock of Marchex, Inc. at a Purchase Price of $2.15 Per Share THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., NEW YORK CITY TIME, ON OCTOBER 7, 2020 UNLESS THE OFFER IS EXTENDED (SUCH DATE AND TIME, AS THEY MAY BE EXTENDE

September 23, 2020 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2020 Marchex, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File N

September 23, 2020 EX-99.(A)(1)(B)

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(a)(1)(B) Exhibit (a)(1)(B) Letter of Transmittal To Tender Shares of Class B Common Stock Pursuant to the Amended and Restated Offer to Purchase for Cash Dated September 23, 2020 by Marchex, Inc. and Edenbrook Capital, LLC of Up to 10,000,000 shares of Class B common stock of Marchex, Inc. at a Purchase Price of $2.15 per share THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE A

September 23, 2020 EX-99.1

Marchex Announces Increase in Purchase Price to $2.15 per share in the Joint Tender Offer with Edenbrook Capital for Up to 10 million Shares of Marchex’s Class B Common Stock

Exhibit 99.1 Marchex Announces Increase in Purchase Price to $2.15 per share in the Joint Tender Offer with Edenbrook Capital for Up to 10 million Shares of Marchex’s Class B Common Stock SEATTLE—(BUSINESSWIRE)— September 23, 2020 – Marchex (NASDAQ: MCHX), a leading conversational analytics company that connects the voice of the customer to your business, announced today an increase in the purchas

September 23, 2020 EX-99.A1B

Letter of Transmittal To Tender Shares of Class B Common Stock Pursuant to the Amended and Restated Offer to Purchase for Cash Dated September 23, 2020 Marchex, Inc. Edenbrook Capital, LLC Up to 10,000,000 shares of Class B common stock Marchex, Inc.

EX-99.(a)(1)(B) Exhibit (a)(1)(B) Letter of Transmittal To Tender Shares of Class B Common Stock Pursuant to the Amended and Restated Offer to Purchase for Cash Dated September 23, 2020 by Marchex, Inc. and Edenbrook Capital, LLC of Up to 10,000,000 shares of Class B common stock of Marchex, Inc. at a Purchase Price of $2.15 per share THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE A

September 23, 2020 EX-99.(A)(1)(A)

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(a)(1)(A) Exhibit (a)(1)(A) Amended and Restated Offer to Purchase for Cash by Marchex, Inc. and Edenbrook Capital, LLC of Up to 10,000,000 shares of Class B common stock of Marchex, Inc. at a Purchase Price of $2.15 per share THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., NEW YORK CITY TIME, ON OCTOBER 7, 2020 UNLESS THE OFFER IS EXTENDED (SUCH DATE AND TIME, A

September 23, 2020 SC TO-I/A

- AMENDMENT NO. 1 TO SCHEDULE TO-I

Amendment No. 1 to Schedule TO-I UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 AMENDMENT NO. 1 MARCHEX, INC. (Name of Subject Company (Issuer)) Marchex, Inc. Edenbrook Capital, LLC Edenbrook Long Only Value Fund, LP Edenbrook Value Fund, LP Jonathan Brolin (Name of

September 23, 2020 SC TO-T/A

MCHX / Marchex, Inc. / Edenbrook Capital, LLC - AMENDMENT NO. 1 TO SCHEDULE TO-T

Amendment No. 1 to Schedule TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 AMENDMENT NO. 1 MARCHEX, INC. (Name of Subject Company (Issuer)) Marchex, Inc. Edenbrook Capital, LLC Edenbrook Long Only Value Fund, LP Edenbrook Value Fund, LP Jonathan Brolin (Name of

September 23, 2020 EX-99.A1C

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(a)(1)(C) Exhibit (a)(1)(C) Notice of Guaranteed Delivery (Not to be used for Signature Guarantee) for Tender of shares of Class B common stock of MARCHEX, INC. THE OFFER PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., NEW YORK CITY TIME, ON OCTOBER 7, 2020, UNLESS THE OFFER IS EXTENDED (SUCH DATE AND TIME, AS THEY MAY BE EXTENDED, THE “EXPIRATION TIME”) As set forth in Sec

September 23, 2020 EX-99.A1E

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(a)(1)(E) Exhibit (a)(1)(E) Offer to Purchase for Cash by Marchex, Inc. and Edenbrook Capital, LLC of Up to 10,000,000 shares of Class B common stock of Marchex, Inc. at a Purchase Price of $2.15 per share THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., NEW YORK CITY TIME, ON OCTOBER 7, 2020, UNLESS THE OFFER IS EXTENDED (SUCH DATE AND TIME, AS THEY MAY BE EXTEND

September 23, 2020 EX-99.(A)(1)(G)

Marchex Announces Increase in Purchase Price to $2.15 per share in the Joint Tender Offer with Edenbrook Capital for Up to 10 million Shares of Marchex’s Class B Common Stock

EX-99.(a)(1)(G) Exhibit (a)(1)(G) Marchex Announces Increase in Purchase Price to $2.15 per share in the Joint Tender Offer with Edenbrook Capital for Up to 10 million Shares of Marchex’s Class B Common Stock SEATTLE—(BUSINESSWIRE)— September 23, 2020 – Marchex (NASDAQ: MCHX), a leading conversational analytics company that connects the voice of the customer to your business, announced today an in

September 23, 2020 EX-99.(A)(1)(C)

You’ve Exceeded the SEC’s Traffic Limit

U.S. Securities and Exchange Commission You’ve Exceeded the SEC’s Traffic Limit Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes. Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains

September 23, 2020 EX-99.(1)(1)(E)

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(1)(1)(E) Exhibit (a)(1)(E) Offer to Purchase for Cash by Marchex, Inc. and Edenbrook Capital, LLC of Up to 10,000,000 shares of Class B common stock of Marchex, Inc. at a Purchase Price of $2.15 per share THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., NEW YORK CITY TIME, ON OCTOBER 7, 2020, UNLESS THE OFFER IS EXTENDED (SUCH DATE AND TIME, AS THEY MAY BE EXTEND

September 23, 2020 SC TO-C

- SC TO-C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

September 4, 2020 CORRESP

-

CORRESP DLA Piper LLP (US) 701 Fifth Avenue Suite 6900 Seattle, Washington 98104-7044 www.

August 31, 2020 SC TO-C

- SC TO-C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

August 31, 2020 EX-99.A1F

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(a)(1)(F) Exhibit (a)(1)(F) Marchex Announces the Commencement of a Joint Tender Offer with Edenbrook Capital for Up to 10 million Shares of Marchex’s Class B Common Stock SEATTLE— (BUSINESSWIRE) — August 31, 2020 – Marchex (NASDAQ: MCHX), a leading conversational analytics company that connects the voice of the customer to your business, announced today the commencement of a joint and equal

August 31, 2020 EX-99.A1E

Offer to Purchase for Cash Marchex, Inc. Edenbrook Capital, LLC Up to 10,000,000 shares of Class B common stock Marchex, Inc. a Purchase Price of – $1.80 per share if up to 6,000,000 shares are tendered, or $1.96 per share if more than 6,000,000 up t

EX-99.(a)(1)(E) Exhibit (a)(1)(E) Offer to Purchase for Cash by Marchex, Inc. and Edenbrook Capital, LLC of Up to 10,000,000 shares of Class B common stock of Marchex, Inc. at a Purchase Price of – $1.80 per share if up to 6,000,000 shares are tendered, or $1.96 per share if more than 6,000,000 up to 10,000,000 shares are tendered THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11

August 31, 2020 EX-99.A1B

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(a)(1)(B) Exhibit (a)(1)(B) Letter of Transmittal To Tender Shares of Class B Common Stock Pursuant to the Offer to Purchase for Cash Dated August 31, 2020 by Marchex, Inc. and Edenbrook Capital, LLC of Up to 10,000,000 shares of Class B common stock of Marchex, Inc. at a Purchase Price of – $1.80 per share if up to 6,000,000 shares are tendered, or $1.96 per share if more than 6,000,000 up

August 31, 2020 EX-99.A1A

Offer to Purchase for Cash Marchex, Inc. Edenbrook Capital, LLC Up to 10,000,000 shares of Class B common stock Marchex, Inc. a Purchase Price of – $1.80 per share if up to 6,000,000 shares are tendered, or $1.96 per share if more than 6,000,000 up t

EX-99.(a)(1)(A) Table of Contents Exhibit (a)(1)(A) Offer to Purchase for Cash by Marchex, Inc. and Edenbrook Capital, LLC of Up to 10,000,000 shares of Class B common stock of Marchex, Inc. at a Purchase Price of – $1.80 per share if up to 6,000,000 shares are tendered, or $1.96 per share if more than 6,000,000 up to 10,000,000 shares are tendered THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS

August 31, 2020 EX-99.A1A

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(a)(1)(A) Table of Contents Exhibit (a)(1)(A) Offer to Purchase for Cash by Marchex, Inc. and Edenbrook Capital, LLC of Up to 10,000,000 shares of Class B common stock of Marchex, Inc. at a Purchase Price of – $1.80 per share if up to 6,000,000 shares are tendered, or $1.96 per share if more than 6,000,000 up to 10,000,000 shares are tendered THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS

August 31, 2020 EX-99.D1

TENDER OFFER AGREEMENT

EX-99.(d)(1) Exhibit (d)(1) TENDER OFFER AGREEMENT THIS TENDER OFFER AGREEMENT (this “Agreement”) is made as of August 31, 2020 (the “Effective Date”), by and between Marchex, Inc., a Delaware corporation (the “Company”), and Edenbrook Capital, LLC, a New York limited liability company (“Edenbrook”). The Company and Edenbrook are at times referred to herein individually as a “Party” and collective

August 31, 2020 SC TO-I

- SC TO-I

SC TO-I UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 MARCHEX, INC. (Name of Subject Company (Issuer)) Marchex, Inc. Edenbrook Capital, LLC Edenbrook Long Only Value Fund, LP Edenbrook Value Fund, LP Jonathan Brolin (Name of Filing Persons (Offerors)) Class B commo

August 31, 2020 EX-99.A1C

Notice of Guaranteed Delivery (Not to be used for Signature Guarantee) Tender of shares of Class B common stock MARCHEX, INC.

EX-99.(a)(1)(C) Exhibit (a)(1)(C) Notice of Guaranteed Delivery (Not to be used for Signature Guarantee) for Tender of shares of Class B common stock of MARCHEX, INC. THE OFFER PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., NEW YORK CITY TIME, ON OCTOBER 7, 2020, UNLESS THE OFFER IS EXTENDED (SUCH DATE AND TIME, AS THEY MAY BE EXTENDED, THE “EXPIRATION TIME”) As set forth in Sec

August 31, 2020 EX-99.A1E

Offer to Purchase for Cash Marchex, Inc. Edenbrook Capital, LLC Up to 10,000,000 shares of Class B common stock Marchex, Inc. a Purchase Price of – $1.80 per share if up to 6,000,000 shares are tendered, or $1.96 per share if more than 6,000,000 up t

EX-99.(a)(1)(E) Exhibit (a)(1)(E) Offer to Purchase for Cash by Marchex, Inc. and Edenbrook Capital, LLC of Up to 10,000,000 shares of Class B common stock of Marchex, Inc. at a Purchase Price of – $1.80 per share if up to 6,000,000 shares are tendered, or $1.96 per share if more than 6,000,000 up to 10,000,000 shares are tendered THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11

August 31, 2020 EX-99.A1B

Letter of Transmittal To Tender Shares of Class B Common Stock Pursuant to the Offer to Purchase for Cash Dated August 31, 2020 Marchex, Inc. Edenbrook Capital, LLC Up to 10,000,000 shares of Class B common stock Marchex, Inc. a Purchase Price of – $

EX-99.(a)(1)(B) Exhibit (a)(1)(B) Letter of Transmittal To Tender Shares of Class B Common Stock Pursuant to the Offer to Purchase for Cash Dated August 31, 2020 by Marchex, Inc. and Edenbrook Capital, LLC of Up to 10,000,000 shares of Class B common stock of Marchex, Inc. at a Purchase Price of – $1.80 per share if up to 6,000,000 shares are tendered, or $1.96 per share if more than 6,000,000 up

August 31, 2020 EX-99.1

Marchex Announces the Commencement of a Joint Tender Offer with Edenbrook Capital for Up to 10 million Shares of Marchex’s Class B Common Stock

Exhibit 99.1 Marchex Announces the Commencement of a Joint Tender Offer with Edenbrook Capital for Up to 10 million Shares of Marchex’s Class B Common Stock SEATTLE—(BUSINESSWIRE)— August 31, 2020 – Marchex (NASDAQ: MCHX), a leading conversational analytics company that connects the voice of the customer to your business, announced today the commencement of a joint and equal tender offer with Eden

August 31, 2020 EX-99.A1D

Offer to Purchase for Cash MARCHEX, INC. EDENBROOK CAPITAL, LLC Up to 10,000,000 Shares of Class B Common Stock of Marchex, Inc. a Purchase Price of – $1.80 Per Share (if up to 6,000,000 shares are tendered), and $1.96 Per Share (if 6,000,000 to 10,0

EX-99.(a)(1)(D) Exhibit (a)(1)(D) Offer to Purchase for Cash by MARCHEX, INC. and EDENBROOK CAPITAL, LLC of Up to 10,000,000 Shares of Class B Common Stock of Marchex, Inc. at a Purchase Price of – $1.80 Per Share (if up to 6,000,000 shares are tendered), and $1.96 Per Share (if 6,000,000 to 10,000,000 shares are tendered) THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M.

August 31, 2020 EX-99.A1D

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(a)(1)(D) Exhibit (a)(1)(D) Offer to Purchase for Cash by MARCHEX, INC. and EDENBROOK CAPITAL, LLC of Up to 10,000,000 Shares of Class B Common Stock of Marchex, Inc. at a Purchase Price of – $1.80 Per Share (if up to 6,000,000 shares are tendered), and $1.96 Per Share (if 6,000,000 to 10,000,000 shares are tendered) THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M.

August 31, 2020 EX-99.A1F

Marchex Announces the Commencement of a Joint Tender Offer with Edenbrook Capital for Up to 10 million Shares of Marchex’s Class B Common Stock

EX-99.(a)(1)(F) Exhibit (a)(1)(F) Marchex Announces the Commencement of a Joint Tender Offer with Edenbrook Capital for Up to 10 million Shares of Marchex’s Class B Common Stock SEATTLE— (BUSINESSWIRE) — August 31, 2020 – Marchex (NASDAQ: MCHX), a leading conversational analytics company that connects the voice of the customer to your business, announced today the commencement of a joint and equal

August 31, 2020 EX-99.A1C

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(a)(1)(C) Exhibit (a)(1)(C) Notice of Guaranteed Delivery (Not to be used for Signature Guarantee) for Tender of shares of Class B common stock of MARCHEX, INC. THE OFFER PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., NEW YORK CITY TIME, ON OCTOBER 7, 2020, UNLESS THE OFFER IS EXTENDED (SUCH DATE AND TIME, AS THEY MAY BE EXTENDED, THE “EXPIRATION TIME”) As set forth in Sec

August 31, 2020 8-K

Financial Statements and Exhibits, Other Events - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

August 31, 2020 EX-99.D1

You’ve Exceeded the SEC’s Traffic Limit

EX-99.(d)(1) Exhibit (d)(1) TENDER OFFER AGREEMENT THIS TENDER OFFER AGREEMENT (this “Agreement”) is made as of August 31, 2020 (the “Effective Date”), by and between Marchex, Inc., a Delaware corporation (the “Company”), and Edenbrook Capital, LLC, a New York limited liability company (“Edenbrook”). The Company and Edenbrook are at times referred to herein individually as a “Party” and collective

August 31, 2020 SC TO-T

MCHX / Marchex, Inc. / Edenbrook Capital, LLC - SC TO-T

SC TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 MARCHEX, INC. (Name of Subject Company (Issuer)) Marchex, Inc. Edenbrook Capital, LLC Edenbrook Long Only Value Fund, LP Edenbrook Value Fund, LP Jonathan Brolin (Name of Filing Persons (Offerors)) Class B commo

August 24, 2020 DEFM14A

Support Services Agreement, dated October 16, 2020, between the Company and Archenia, Inc. (incorporated by reference to Annex A of the Proxy Statement, as filed with the SEC on August 24, 2020).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin

August 21, 2020 8-K/A

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (

August 20, 2020 DEFA14A

- DEFA14A 2020 - ADDITIONAL MATERIALS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

August 20, 2020 DEF 14A

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin

August 14, 2020 PRE 14A

- PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

August 10, 2020 8-K

Financial Statements and Exhibits, Other Events - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

August 10, 2020 SC 13D/A

MCHX / Marchex, Inc. / Edenbrook Capital, LLC - MARCHEX, INC. Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 15) Marchex, Inc. (Name of Issuer) Class B common stock, par value $0.01 per share (Title of Class of Securities) 56624R108 (CUSIP Number) Jonathan Brolin Edenbrook Capital, LLC 116 Radio Circle Mount Kisco, NY 10549 (914) 239-3117 (Name, Address and Telep

August 10, 2020 SC TO-C

- SC TO-C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

August 10, 2020 8-K

Entry into a Material Definitive Agreement - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numbe

August 10, 2020 DEFA14A

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

August 10, 2020 SC TO-C

- SC TO-C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

August 10, 2020 10-Q

Quarterly Report - 10-Q

f UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex

August 10, 2020 EX-99.1

Marchex Announces Second Quarter 2020 Results Announces Intent to Divest Media Assets to Focus on the Conversational Analytics and Sales Engagement Solutions Opportunity

Exhibit 99.1 Marchex Announces Second Quarter 2020 Results Announces Intent to Divest Media Assets to Focus on the Conversational Analytics and Sales Engagement Solutions Opportunity SEATTLE – August 10, 2020- Marchex, Inc. (NASDAQ:MCHX), a leading conversational analytics company that connects the voice of the customer to your business, today announced its financial results for the second quarter

August 10, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numb

August 10, 2020 EX-99.1

Marchex Announces Intent to Conduct Joint Tender Offer with Edenbrook Capital

Exhibit 99.1 Marchex Announces Intent to Conduct Joint Tender Offer with Edenbrook Capital SEATTLE—(BUSINESSWIRE)— August 10, 2020 – Marchex (NASDAQ: MCHX), a leading conversational analytics company that connects the voice of the customer to your business, announced today the intent to launch a joint and equal tender offer with Edenbrook Capital, LLC (“Edenbrook”) to purchase up to 10.0 million s

August 10, 2020 DEFA14A

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numbe

May 22, 2020 10-Q/A

Quarterly Report - 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Numbe

May 19, 2020 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex,

May 15, 2020 8-K/A

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numbe

May 11, 2020 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number)

May 11, 2020 EX-99.1

Marchex Announces First Quarter 2020 Results

Exhibit 99.1 Marchex Announces First Quarter 2020 Results SEATTLE – May 11, 2020- Marchex, Inc. (NASDAQ:MCHX), a leading conversational analytics and solutions company that connects the voice of the customer to your business, today announced its financial results for the first quarter ended March 31, 2020. Q1 2020 Financial Highlights • Revenue was $24.8 million for the first quarter of 2020, comp

May 11, 2020 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number)

May 11, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number)

May 8, 2020 EX-10.1

Note, dated as of May 4, 2020, by and between Marchex, Inc. and Silicon Valley Bank.

EX-10.1 2 mchx-ex1017.htm EX-10.1 Exhibit 10.1 Silicon Valley Bank U.S. Small Business Administration Paycheck Protection Program Note SBA Loan No. 4123277210 SBA Loan Name Borrower Legal Name Marchex, Inc. DBA Date 5/4/2020 Loan Amount $ 3970587 Interest Rate 1.0% per annum Borrower Marchex, Inc. Operating Company Not applicable Lender Silicon Valley Bank 1. PROMISE TO PAY. In return for the Loan

May 8, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number)

May 8, 2020 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number)

April 28, 2020 EX-31.I

Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31(i) CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Michael A.

April 28, 2020 10-K/A

Annual Report - 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marc

March 24, 2020 EX-99.1

Marchex Provides Corporate Update

Exhibit 99.1 Marchex Provides Corporate Update SEATTLE—(BUSINESSWIRE)— March 24, 2020 – Marchex, Inc. (NASDAQ: MCHX), a leading conversational analytics company that connects the voice of the customer to your business, announced that due to the growing impact from the COVID-19 outbreak and the resulting uncertainties and disruptions to our customers, at this time the company is withdrawing its pre

March 24, 2020 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Numbe

March 23, 2020 S-8

MCHX / Marchex, Inc. S-8 - - S-8

As filed with the Securities and Exchange Commission on March 23, 2020 Registration No.

March 13, 2020 EX-2.7

Equity Purchase Agreement, dated as of December 13, 2019, by and among the Registrant, Sonar Technologies, Inc., the Sellers and Fortis Advisers LLC, as Securityholder Representative.

Exhibit 2.7 NOTE: CERTAIN IDENTIFIED INFORMATION IN THIS AGREEMENT HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SUCH PORTIONS HAVE BEEN REDACTED AND ARE MARKED WITH A “[***]” IN PLACE OF THE REDACTED LANGUAGE. EQUITY PURCHASE AGREEMENT BY AND AMONG MARCHEX, INC. SONAR TECHNOLOGIES, INC. THE SELLERS AND FORTIS

March 13, 2020 10-K

Our Annual Report on Form 10-K for the year ended December 31, 2019;

Since this UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-50658 Marc

March 13, 2020 EX-21.1

Subsidiaries of the Registrant.

EX-21.1 5 mchx-ex2117.htm EX-21.1 Exhibit 21.1 List of Subsidiaries of the Registrant Name Jurisdiction 1. Marchex Paymaster, LLC Delaware 2. goClick.com, Inc. Delaware 3. Marchex, LLC Delaware 4. Marchex Sales, LLC Delaware 5. Marchex CAH, Inc. Delaware 6. Telmetrics Corporation (formerly, Telmetrics Inc.) Nova Scotia 7. Marchex International, Ltd. Ireland 8. Marchex Voice Services, Inc. Pennsylv

March 13, 2020 EX-10.41

Amendment No. 7 to Master Services and License Agreement, effective as of December 31, 2019, by and between Marchex Sales, LLC, a Delaware limited liability company (formerly Marchex Sales, Inc.) and Thryv, Inc. (f/k/a Dex Media, Inc.), successor in interest to YellowPages.com LLC (formally d/b/a AT&T Interactive or ATTi).

Exhibit 10.41 AMENDMENT NO. 7 TO MASTER SERVICES AND LICENSE AGREEMENT This Amendment No. 7 (“Amendment No. 7”), effective as of December 31, 2019 (the “Amendment 7 Effective Date”), is being entered into by and between Marchex Sales LLC, a Delaware limited liability company formerly known as Marchex Sales, Inc., which is a wholly-owned subsidiary of Marchex, Inc. (“Marchex”), and Thryv, Inc. (f/k

March 13, 2020 EX-10.42

Amendment No. 5 to Pay-For-Call Distribution Agreement, effective as of December 31, 2019, by and between Marchex Sales, LLC, a Delaware limited liability company (formerly Marchex Sales, Inc.) and Thryv, Inc. (f/k/a Dex Media, Inc.), successor in interest to YellowPages.com LLC (formally d/b/a AT&T Interactive or ATTi).

Exhibit 10.42 AMENDMENT NO. 5 TO PAY-FOR-CALL DISTRIBUTION AGREEMENT This Amendment No. 5 (“Amendment No. 5”), effective as of December 31, 2019 (the “Amendment 5 Effective Date”), is being entered into by and between Marchex Sales LLC, a Delaware limited liability company formerly known as Marchex Sales, Inc., which is a wholly-owned subsidiary of Marchex, Inc. (“Marchex”), and Thryv, Inc. (f/k/a

March 13, 2020 EX-31.I

Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31(i) CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Michael A.

March 12, 2020 SC 13D

MCHX / Marchex, Inc. / HARBERT MICROCAP PARTNERS FUND, LP Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.

March 3, 2020 EX-99.1

Marchex Announces New Chief Product and Strategy Officer

Exhibit 99.1 Marchex Announces New Chief Product and Strategy Officer SEATTLE—(BUSINESSWIRE)— March 3, 2020 - Marchex (NASDAQ: MCHX), a leading conversational analytics company that connects the voice of the customer to your business, announced that it has hired Ryan Polley as Chief Product and Strategy Officer. In this role, Polley will lead Marchex’s product and engineering organizations. Polley

March 3, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2020 Marchex, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 000-50658 35-2194038 (State or other jurisdiction of incorporation) (Commission File Number

Other Listings
DE:NHM € 1.66
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista